Roivant Sciences (ROIV) Share-based Compensation (2020 - 2026)
Roivant Sciences' Share-based Compensation was $83.34 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 1.4% from $82.18 million a year earlier and up 8.0% from the prior quarter.
Roivant Sciences (ROIV) Share-based Compensation (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Roivant Sciences' Share-based Compensation was $347.33 million through Jun 30, 2026, up 8.2% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $346.17 million, up 19.8% from FY2025.
- Share-based Compensation shows a five-year compound annual growth rate of 32.4% (FY2021 to FY2026).
- In earlier fiscal years, Share-based Compensation was $289.03 million in FY2025 (+44.8%), $199.63 million in FY2024 (-8.3%), $217.78 million in FY2023 (-61.5%) and $564.96 million in FY2022 (+565.0%).
- Quarterly Share-based Compensation has moved between $25.28 million (fiscal Q4 2023) and $397.31 million (fiscal Q2 2022) over five years.
- Compared with a year earlier, Share-based Compensation was higher in seven of the last eight quarters, with growth averaging 34.4%.
- The best year-over-year quarter for Share-based Compensation over five years was fiscal Q3 2022 (growth of 311.1%); the worst was fiscal Q2 2023 (a decline of 84.4%).
- Per Business Quant data, ROIV's Share-based Compensation in the three fiscal quarters before Q1 2027 was $77.17 million (Q4 2026), $105 million (Q3 2026) and $81.82 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Roivant Sciences | 25.19 Bn | 8.14 Bn | 1.16 Mn | 83.34 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.34 Mn |
| Mar 31, 2026 | 77.17 Mn |
| Dec 31, 2025 | 105.00 Mn |
| Sep 30, 2025 | 81.82 Mn |
| Jun 30, 2025 | 82.18 Mn |
| Mar 31, 2025 | 83.49 Mn |
| Dec 31, 2024 | 83.68 Mn |
| Sep 30, 2024 | 71.67 Mn |
| Jun 30, 2024 | 50.19 Mn |
| Mar 31, 2024 | 46.72 Mn |
| Dec 31, 2023 | 54.33 Mn |
| Sep 30, 2023 | 49.32 Mn |
| Jun 30, 2023 | 49.26 Mn |
| Mar 31, 2023 | 25.28 Mn |
| Dec 31, 2022 | 57.73 Mn |
| Sep 30, 2022 | 61.98 Mn |
| Jun 30, 2022 | 72.79 Mn |
| Mar 31, 2022 | 77.16 Mn |
| Dec 31, 2021 | 71.22 Mn |
| Sep 30, 2021 | 397.31 Mn |
Roivant Sciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();